Beutel Goodman Cuts AMGN Stake

Beutel Goodman & Co Ltd., an institutional investor, has made changes to its holdings in Amgen Inc. (NASDAQ: AMGN) shares. According to a recent Form 13F filing with the Securities and Exchange Commission, Beutel Goodman lowered its holdings by 19.8% during the second quarter.

The company now owns approximately 0.10% of Amgen's stock, valued at $188,511,000 as of the end of the most recent reporting period. This follows a sale of 128,742 shares during the quarter.

Apart from Beutel Goodman, other large investors have also adjusted their stakes in Amgen. Anfield Capital Management LLC boosted its position by 1,000% in the fourth quarter, while Dogwood Wealth Management LLC lifted its stake by 275% during the same period.